71 results
6-K
EX-99.1
CNTG
Centogene NV
29 Feb 24
Complete Pre-TCRα Deficiency Found to be Very Rare, Partial Form More Common Than Expected
5:00pm
. Critically, the depth and breadth of the CENTOGENE Biodatabank provided the power to confirm the genotype-phenotype association in an independent real
6-K
EX-99.1
CNTG
Centogene NV
28 Feb 24
CENTOGENE Explores Strategic Alternatives
6:30am
appointed a special committee, consisting of independent members, to oversee the exploration and evaluation of potential strategic alternatives … , and/or continuing to operate as an independent public company.
There can be no assurance that the Company’s strategic review process will result in any
6-K
EX-99.1
CNTG
Centogene NV
23 Jan 24
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
6:36am
of harmful substances in nerve cells. This accumulation, as well as potentially other independent consequences of GBA dysfunction, can contribute
6-K
EX-99.1
CNTG
Centogene NV
18 Jan 24
CENTOGENE Announces Preliminary Full Year 2023 Revenue
7:02am
and records of the Company, which have yet to be fully performed, as well as completion of audit procedures by the Company’s independent public accountants … for its second half and full year ended December 31, 2023, and actual results may differ materially from those described above. No independent registered
6-K
EX-99.2
CNTG
Centogene NV
28 Nov 23
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
6:30am
Affiliates at all times shall be deemed an independent contractor and neither it nor any of its Affiliates or any of their respective employees, directors … to an independent professional firm chosen and/or appointed by Company, provided such auditor is reasonably acceptable to NV.
Good Faith
NV will act
6-K
EX-99.3
fx7m1c316csea4
28 Nov 23
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
6:30am
6-K
EX-99.4
quo4qhegre
28 Nov 23
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
6:30am
6-K
EX-99.3
0bs46tpj3 hu
27 Oct 23
Variation Agreement to Joint Venture Agreement
7:28am
6-K
EX-99.2
p05tvhhszpcf9 5m
27 Oct 23
Variation Agreement to Joint Venture Agreement
7:28am
6-K
EX-99.4
xddj6kcmxta 1jsfl
27 Oct 23
Variation Agreement to Joint Venture Agreement
7:28am
6-K
EX-99.5
mcugd2v
27 Jun 23
Current report (foreign)
9:36am
6-K
EX-99.3
wr333
27 Jun 23
Current report (foreign)
9:36am
6-K
EX-99.2
lprxbhm
27 Jun 23
Current report (foreign)
9:36am
6-K
EX-99.4
erjul ytuibjwkelx4f
27 Jun 23
Current report (foreign)
9:36am
6-K
EX-99.1
spsyn13c6a7ex
13 Jun 23
Current report (foreign)
6:00am
6-K
EX-99.1
uzcjm78 2u
4 May 23
Second Amendment to Loan and Security Agreement
4:18pm